CV (CapsoVision) Buyback Yield %: -3.78 (As of Jun. 29, 2026)


CV CapsoVision Inc CV
10 GF Score
Price $7.42
! 1 Warning Sign
View Full Analysis

What is CapsoVision Buyback Yield %?

CapsoVision CV +7.58% 10 Buyback Yield % is -3.78 as of Jun. 29, 2026. GuruFocus rates CV with a GF Score™ of 10/100. The stock has 1 warning sign investors should review. Among 345 Medical Devices & Instruments companies, CapsoVision ranks worse than 60.87% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

CapsoVision's current buyback yield was -3.78%.


CapsoVision Buyback Yield % Historical Data

* Premium members only.

The historical data trend for CapsoVision's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CapsoVision Buyback Yield % Chart

CapsoVision Annual Data
Trend Dec23 Dec24 Dec25
Buyback Yield %
0.00 0.00 -5.30

CapsoVision Quarterly Data
Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 -5.30 -3.85

CV vs OFIX, CATX, ELMD: Buyback Yield % Comparison

For the Medical Devices subindustry, CapsoVision's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CapsoVision Buyback Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CapsoVision's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where CapsoVision's Buyback Yield % falls into.


CV
10GF Score
CapsoVision Inc CV
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CapsoVision Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

CapsoVision's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 26.557) / 500.98685
=-5.30%

CapsoVision's annualized Buyback Yield for the quarter that ended in Mar. 2026 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 14) / 363.32631
=-3.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -3.78 mean?
CapsoVision (CV) has a Buyback Yield % of -3.78 as of Jun. 29, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CapsoVision and its competitors. According to the industry distribution chart, CapsoVision ranks #210 out of 345 companies in the Medical Devices & Instruments industry, placing it in the top 60.9%.
Is CapsoVision's Buyback Yield % too high?
CapsoVision's current Buyback Yield % is -3.78. Based on the distribution chart, CapsoVision ranks #210 out of 345 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CapsoVision has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does CapsoVision's Buyback Yield % compare to OFIX and CATX?
According to the Medical Devices & Instruments industry distribution chart, CapsoVision ranks #210 out of 345 companies for Buyback Yield %. This places CapsoVision in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Devices & Instruments company?
A good Buyback Yield % depends on the Medical Devices & Instruments industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on CapsoVision and its competitors. CapsoVision's current Buyback Yield % is -3.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CapsoVision stock overvalued right now?
CapsoVision (CV) has a current Buyback Yield % of -3.78. The current Buyback Yield % is -3.78. CapsoVision's overall GF Score™ is 10/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For CapsoVision (CV), the current Buyback Yield % is -3.78 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

CapsoVision Business Description

Other Exchanges H6U:Germany
Address 18805 Cox Avenue, Suite 250, Saratoga, CA, USA, 95070
CapsoVision Inc is a commercial-stage medical technology enterprise that innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. The company's core technology platform is an orally ingestible capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. CapsoVision's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D, directed at the large intestines. Geographically, the company generates the majority of its revenue from the United States.
10GF Score

Get the complete analysis for CV

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.42
Price